Physician profile
Matthew Smith
NPI 1144604398
$8,787.50
in general payments reported to CMS, 2019-2025
45 companies · $1,186 in 2025
The $1,186 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $172 · 2021: $314 · 2022: $787 · 2023: $4,621 · 2024: $1,708 · 2025: $1,186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,943 · Travel and Lodging: $2,558 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,942.88 |
| Travel and Lodging | $2,558.46 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,529.29 | 2020-2025 | Moses 550 D\F\L, Ams 700, Lithovue |
| Procept Biorobotics Corporation | $2,061.57 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $444.18 | 2020-2024 | Myrbetriq, Xtandi |
| Abbvie INC. | $340.93 | 2022-2025 | Botox |
| Urogen Pharma, INC. | $307.87 | 2022-2025 | Jelmyto |
| Janssen Scientific Affairs, LLC | $302.69 | 2022-2025 | Erleada, Akeega, Pipeline |
| Medtronic, INC. | $283.66 | 2021-2024 | Interstim |
| Laborie Medical Technologies Corp. | $261.67 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Progenics Pharmaceuticals, INC. | $233.81 | 2022-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $223.35 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $160.11 | 2023-2025 | Orgovyx, Gemtesa |
| Convatec INC. | $116.76 | 2022-2023 | |
| Kerecis Limited | $104.47 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Srs Medical Systems, INC. | $93.57 | 2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Dentsply Ih Ab | $91.86 | 2023-2025 | Lofric, Lofric |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $89.54 | 2023 | Provenge |
| Urovant Sciences INC | $87.87 | 2022 | |
| Axonics, INC. | $86.30 | 2023-2024 | Axonics |
| C. R. Bard, INC. & Subsidiaries | $77.85 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Teleflex LLC | $75.71 | 2022 | |
| Amgen INC. | $62.70 | 2023 | Prolia, Xgeva |
| Janssen Biotech, INC. | $60.03 | 2022-2024 | Erleada, Akeega |
| Tolmar, INC. | $57.95 | 2023-2025 | Jatenzo |
| 180 Medical, INC. | $50.50 | 2024-2025 | Cure Catheter, Gentlecath |
| Accord Healthcare, INC. | $50.03 | 2023-2024 | |
| Tempus Ai, INC | $48.65 | 2025 | Xt Cdx |
| Exelixis INC. | $47.11 | 2022 | |
| Novartis Pharmaceuticals Corporation | $44.46 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $38.44 | 2023-2024 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $37.16 | 2021-2022 | |
| Edap Technomed INC | $33.60 | 2023 | |
| Supernus Pharmaceuticals, INC. | $29.52 | 2021 | |
| Myovant Sciences INC. | $29.33 | 2022 | |
| Genzyme Corporation | $27.68 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $26.69 | 2022 | |
| Hollister Incorporated | $25.61 | 2021 | |
| Caris Mpi, INC. | $20.69 | 2025 | Mi Cancer Seek |
| Pfizer INC. | $19.64 | 2025 | |
| Daiichi Sankyo INC. | $17.66 | 2022 | |
| Coloplast Corp | $17.59 | 2024 | |
| Koelis INC. | $15.92 | 2023 | |
| Davol INC. | $15.21 | 2021 | |
| Photocure INC | $13.56 | 2025 | Cysview |
| Verity Pharmaceuticals INC. | $13.08 | 2023 | Trelstar |
| Tolmar Pharmaceuticals, INC. | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.